---
figid: PMC3153009__fphar-01-00135-g003
figtitle: Main signaling pathways that mediate visfatin/PBEF/Nampt-induced endothelial
  cell proliferation and migration
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC3153009
filename: fphar-01-00135-g003.jpg
figlink: /pmc/articles/PMC3153009/figure/F3/
number: F3
caption: Main signaling pathways that mediate visfatin/PBEF/Nampt-induced endothelial
  cell proliferation and migration. Visfatin/PBEF/Nampt promotes vascular endothelial
  growth factor (VEGF) synthesis and secretion and up-regulates the expression of
  the VEGF receptor 2. Visfatin/PBEF/Nampt favors the endothelial production of nitric
  oxide (NO), a promoter of VEGF release, by activating endothelial nitric oxide synthase
  (eNOS) via the PI3K/Akt pathway. NO production is further enhanced through the activation
  of dimethylarginine dimethylaminohydrolase (DDAH), which degrades the eNOS inhibitor
  asymmetric dimethylarginine (ADMA). Additionally, visfatin/PBEF/Nampt triggers the
  endothelial production of other pro-angiogenic molecules, such as monocyte chemoatractant
  protein (MCP)-1 and fibroblast growth factor (FGF)-2. On the other hand, visfatin/PBEF/Nampt
  enhances the levels and activation of matrix metalloproteinases (MMP)-2/9 while
  decreasing the levels of tissue inhibitor of metalloproteinases (TIMP)-1/2.
papertitle: 'Visfatin/PBEF/Nampt: A New Cardiovascular Target?.'
reftext: Concepción Peiró, et al. Front Pharmacol. 2010;1:135.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9580606
figid_alias: PMC3153009__F3
figtype: Figure
redirect_from: /figures/PMC3153009__F3
ndex: de33ae78-dee4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3153009__fphar-01-00135-g003.html
  '@type': Dataset
  description: Main signaling pathways that mediate visfatin/PBEF/Nampt-induced endothelial
    cell proliferation and migration. Visfatin/PBEF/Nampt promotes vascular endothelial
    growth factor (VEGF) synthesis and secretion and up-regulates the expression of
    the VEGF receptor 2. Visfatin/PBEF/Nampt favors the endothelial production of
    nitric oxide (NO), a promoter of VEGF release, by activating endothelial nitric
    oxide synthase (eNOS) via the PI3K/Akt pathway. NO production is further enhanced
    through the activation of dimethylarginine dimethylaminohydrolase (DDAH), which
    degrades the eNOS inhibitor asymmetric dimethylarginine (ADMA). Additionally,
    visfatin/PBEF/Nampt triggers the endothelial production of other pro-angiogenic
    molecules, such as monocyte chemoatractant protein (MCP)-1 and fibroblast growth
    factor (FGF)-2. On the other hand, visfatin/PBEF/Nampt enhances the levels and
    activation of matrix metalloproteinases (MMP)-2/9 while decreasing the levels
    of tissue inhibitor of metalloproteinases (TIMP)-1/2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - adma
  - vegfaa
  - mmp9
  - mmp2
  - fgf2
  - timp2a
  - NAMPT
  - LARP1BP2
  - RNU6-392P
  - NAMPT-AS1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - NOS3
  - ENO4
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - CCL2
  - MMP9
  - MMP2
  - FGF2
  - TIMP1
  - TIMP2
  - L-Arginine
---
